Subsequently, the risk of seizures was found to be highly dose-dependent, and bupropion was re-introduced to the market in 1989 with a lower maximum recommended daily dose.
Naknadno je ustanovljeno da je rizik od napada jako zavistan od doze, i bupropion je vraćen u prodaju 1989. sa maksimalnom preporučenom dozom od 450 mg/dan.